In this episode of MedTech Global Insights, we dissect the FDA's groundbreaking final guidance on Predetermined Change Control Plans (PCCPs) for AI/ML-enabled medical devices. We explore how this new framework moves beyond the traditional, rigid regulatory submission process, creating a streamlined pathway for manufacturers to innovate and improve their smart devices safely and effectively. Discover how a PCCP can unlock the full potential of your adaptive medical software. We'll use the example of an AI-powered diagnostic imaging tool that continuously learns from new data. The pain point is clear: without a PCCP, every minor algorithm update could mean a new, costly submission to the FDA, stalling innovation. With a well-crafted PCCP, the company can deploy performance-enhancing updates swiftly, as long as they fall within the pre-approved plan, ensuring patients get the best technology faster. Key Takeaways: - What is an FDA Predetermined Change Control Plan and why is it a game-changer for AI/ML medical devices? - How do you define the scope of planned modifications without limiting future innovation? - What are the essential components of a "Modification Protocol" that will satisfy regulators? - How can you demonstrate that your device will remain safe and effective after multiple algorithm updates? - What are the best practices for documenting the verification and validation process for each change? - How does a PCCP impact the post-market surveillance and reporting requirements for your device? - What common pitfalls should manufacturers avoid when preparing their PCCP submission? - How can a strategic regulatory partner help you leverage the PCCP framework for faster global market access? Contact us at [email protected] or visit https://pureglobal.com/ for more information.